glp 1 and 2 Dual GIP/GLP-1 receptor agonists: New advances for treating type-2 diabetes Clinical Focus on GLP-1 Agonists

Discouraging clinical read-through: The most advanced human program on the same HGF/c-Met hypothesis (a different molecule, fosgonimeton) failed its primary endpoint in the Phase 2/3 LIFT-AD Alzheimers trial [6] [7]

Kolberg M, Holand M, Agesen TH, Brekke HR, Liestol K, Hall KS, et al

Astaxanthin supplementation can benefit eye health in a few different ways

Prevalence of Gout and Hyperuricemia in the US General Population: the National Health and Nutrition Examination Survey 2007-2008

cohort study, the 2-year discontinuation rate for GLP-1 receptor agonists was 64.1% among people with type 2 diabetes mellitus, driven by factors such as older age, low income, gastrointestinal adverse events, and insufficient weight loss [115]

Awesome people and superior products Thank for great service I started peptide therapy approximately a month and a half ago and Ive tried several companies